In brief, what’s happening at Penn—whether it’s across campus or around the world.
The Orphan Disease Center was established at Penn a decade ago to facilitate and fund research, and develop transformative therapies for rare diseases. The ODC fields two flagship programs to promote research, while JumpStart collaborates with rare disease communities to provide expertise and pilot grants to collect information and develop research toward treatments.
FULL STORY AT The Pennsylvania Gazette →
A new study from Penn Nursing’s Center for Health Outcomes and Policy Research has investigated associations between EHR usability and nurse job outcomes (burnout, job dissatisfaction, and intention to leave) and surgical patient outcomes (inpatient mortality and 30-day readmission). The study found that employing EHR systems with suboptimal usability was associated with higher odds of adverse nurse job outcomes and surgical patient mortality and readmission.
FULL STORY AT Penn Nursing News →
This year, Penn Dental Medicine represents three of the four students appointed to serve on National American Student Dental Association. Second-year student Ryan Kaminsky was elected District 3 Trustee on the Board of Trustees. Julie Berenblum was appointed Council on Membership Associate, and first-year student Hilary Wong was appointed Council on Communications Associate.
FULL STORY AT Penn Dental Medicine →
After a team of researchers showed that a certain enzyme’s presence in cartilage increased significantly in people with osteoarthritis, they targeted it with specially-loaded nanoparticles that stopped the disease’s progression in its tracks. The enzyme is largely overlooked when it comes to osteoarthritis, but the research shows it could be key to new, effective treatment for the disease.
FULL STORY AT Penn Medicine News →
In a new study, Penn Medicine researchers show that a new hyaluronic acid hydrogel system can reinforce and seal areas of injured cartilage.
FULL STORY AT Penn Medicine News →
APenn study finds that mailing free naloxone and other harm reduction supplies discreetly and confidentially to people’s homes is an effective yet largely underutilized strategy for increasing access to life-saving harm reduction supplies, one that policymakers should explicitly support given the urgent need.
FULL STORY AT Leonard Davis Institute →
A clinical trial is underway to test a Penn-developed compression tool called an “Oscipulse” to promote blood flow in order to prevent deep-vein thrombosis.
FULL STORY AT Penn Medicine News →
In an attempt to examine how the most recent Atlanta shooting and ongoing acts of anti-Asian violence have affected some of Penn’s medical students, the Perelman School of Medicine solicited volunteers who were willing to share how their race and ethnicity have affected different aspects of their medical education and identities.
FULL STORY AT Center for Health Equity Advancement →
The Diversity and Equity award recognizes an ISPN member who has demonstrated outstanding leadership in providing culturally-sensitive mental health services. Brawner has conducted extensive research into the factors influencing HIV and AIDS among Black residents of Philadelphia, and focuses on how mental health conditions, such as depression in Black youth, correlate with unhealthy behaviors. In her clinical work, she partners with behavioral health providers on interventions for adolescents with mental illness and works with youth affected by HIV/AIDS.
FULL STORY AT Penn Nursing News →
The Penn Nerve Center combines experts in neurosurgery, orthopaedic surgery, plastic surgery, and physical therapy to offer expert diagnosis and treatment for a range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumors.
FULL STORY AT Penn Medicine News →
